Krystof, V.
92  Ergebnisse:
Personensuche X
?
2

Anti‐angiogenic effects of novel cyclin‐dependent kinase in..:

Zhang, S ; Ulrich, M ; Gromnicka, A...
British Journal of Pharmacology.  173 (2016)  17 - p. 2645-2656 , 2016
 
?
3

500 A novel pyrazolo[4,3-d]pyrimidine inhibitor of cyclin-d..:

Jorda, R. ; Reznickova, E. ; Krystof, V...
European Journal of Cancer Supplements.  8 (2010)  7 - p. 159-160 , 2010
 
?
4

Active p53 contributes to antitumor effects of cyclin-depen..:

Krystof, V. ; Paprskarova, M. ; Strnad, M.
European Journal of Cancer Supplements.  6 (2008)  9 - p. 140-141 , 2008
 
?
5

Biochemical and cellular effects of a novel cyclin-dependen..:

Jorda, R. ; Krystof, V. ; Havlícek, L..
European Journal of Cancer Supplements.  6 (2008)  9 - p. 84 , 2008
 
?
6

Antiproliferative activity of olomoucine II, a novel 2,6,9-..:

Kryštof, V. ; McNae, I. W. ; Walkinshaw, M. D....
Cellular and Molecular Life Sciences.  62 (2005)  15 - p. 1763-1771 , 2005
 
?
8

Characterization of new highly selective pyrazolo[4,3 d]pyr..:

Kovalova, M ; Havlicek, L ; Djukic, S...
http://www.helmholtz-berlin.de/pubbin/oai_publication?VT=1&ID=109399.  , 2023
 
?
10

Anti‐angiogenic effects of novel cyclin‐dependent kinase in..:

Zhang, S ; Ulrich, M ; Gromnicka, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978162/.  , 2016
 
1-15